We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.51%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$28.5B
AUM Growth
+$2.42B
(+9.3%)
Cap. Flow
+$581M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
VF Corp
VFC
|
+$73.4M |
| 3 |
Amazon
AMZN
|
+$71M |
| 4 |
Stanley Black & Decker
SWK
|
+$60.2M |
| 5 |
Tesla
TSLA
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$158M |
| 2 |
Apple
AAPL
|
+$130M |
| 3 |
Cardinal Health
CAH
|
+$43.7M |
| 4 |
Fortinet
FTNT
|
+$39.6M |
| 5 |
ExxonMobil
XOM
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.73% |
| 2 | Industrials | 12.07% |
| 3 | Consumer Staples | 11.64% |
| 4 | Healthcare | 11.12% |
| 5 | Financials | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Rambus
RMBS
$10.4B
| $605K | ﹤0.01% |
16,888
+1,793
| +12% | +$60.6K |
|
|
SYNH
877
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $602K | ﹤0.01% |
16,412
+531
| +3% | +$21K |
|
878
Atkore
ATKR
$2.59B
| $602K | ﹤0.01% |
5,304
+760
| +17% | +$79.5K |
|
879
Vir Biotechnology
VIR
$1.47B
| $600K | ﹤0.01% |
23,703
+1,288
| +6% | +$31.6K |
|
|
AQUA
880
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $599K | ﹤0.01% |
15,138
+2,171
| +17% | +$85.4K |
|
881
Jabil
JBL
$32.8B
| $598K | ﹤0.01% |
8,770
+873
| +11% | +$57.7K |
|
882
Blackbaud
BLKB
$1.5B
| $595K | ﹤0.01% |
10,111
+990
| +11% | +$55.5K |
|
883
Axsome Therapeutics
AXSM
$12.4B
| $595K | ﹤0.01% |
7,715
+1,047
| +16% | +$62.6K |
|
|
BPMC
884
DELISTED
Blueprint Medicines
BPMC
| $593K | ﹤0.01% |
13,544
+990
| +8% | +$47.5K |
|
885
ATI
ATI
$27B
| $590K | ﹤0.01% |
19,747
+2,525
| +15% | +$73.9K |
|
886
BlackLine
BL
$1.69B
| $589K | ﹤0.01% |
8,756
+848
| +11% | +$52.6K |
|
|
ISEE
887
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $584K | ﹤0.01% |
27,299
+4,301
| +19% | +$91.8K |
|
888
EnerSys
ENS
$6.95B
| $584K | ﹤0.01% |
7,909
+1,080
| +16% | +$75.4K |
|
889
Chemed
CHE
$6.78B
| $584K | ﹤0.01% |
1,144
+94
| +9% | +$45.8K |
|
|
NARI
890
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $584K | ﹤0.01% |
9,182
+1,239
| +16% | +$89.8K |
|
|
FL
891
DELISTED
Foot Locker
FL
| $583K | ﹤0.01% |
15,430
+1,865
| +14% | +$64K |
|
892
Beam Therapeutics
BEAM
$2.58B
| $583K | ﹤0.01% |
14,901
+1,036
| +7% | +$46.4K |
|
893
Belden
BDC
$4B
| $583K | ﹤0.01% |
8,103
+963
| +13% | +$69.9K |
|
894
Performance Food Group
PFGC
$17.5B
| $579K | ﹤0.01% |
9,922
+1,196
| +14% | +$65.2K |
|
|
NSA
895
DELISTED
National Storage Affiliates Trust
NSA
| $577K | ﹤0.01% |
15,970
+941
| +6% | +$36.8K |
|
896
Acadia Healthcare
ACHC
$3.17B
| $575K | ﹤0.01% |
6,983
+574
| +9% | +$47.3K |
|
|
ESGR
897
DELISTED
Enstar Group
ESGR
| $574K | ﹤0.01% |
2,485
+335
| +16% | +$68.2K |
|
898
CNX Resources
CNX
$4.85B
| $574K | ﹤0.01% |
34,071
+3,075
| +10% | +$53.1K |
|
899
Texas Capital Bancshares
TCBI
$4.31B
| $573K | ﹤0.01% |
9,507
+1,266
| +15% | +$74.8K |
|
900
SLM Corp
SLM
$4.57B
| $573K | ﹤0.01% |
34,527
+3,906
| +13% | +$64K |
|
Similar funds
ProShare Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, ProShare Advisors held 1,921 positions worth $28.5B, up 9.3% from $26.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors's Q4 2022 filing shows 171 new, 1,320 increased, 356 reduced and 71 closed positions. Its largest new stake was Rivian: 689,839 shares worth $12.7M. The largest sale was Target, an estimated $158M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q4 2022 buy was Rivian: 689,839 shares worth $12.7M.
- ProShare Advisors added most to Microsoft in Q4 2022, an estimated $111M increase.
- ProShare Advisors's biggest Q4 2022 reduction was Apple, cutting an estimated $130M.
- ProShare Advisors fully exited Target in Q4 2022, selling an estimated $158M.
- ProShare Advisors's ten largest holdings make up 20% of its $28.5B portfolio in Q4 2022.
- ProShare Advisors opened 171 new positions and closed 71 in Q4 2022.
- ProShare Advisors's portfolio value rose 9.3% quarter-over-quarter to $28.5B.
Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.